| Good Samaritan Hospital Association | |
| 800 S Main Ave, Rugby, North Dakota 58368 | |
| (701) 776-5261 |
| Name | Good Samaritan Hospital Association |
|---|---|
| Organization Name | Good Samaritan Hospital Association |
| Location | 800 S Main Ave, Rugby, North Dakota 58368 |
| Type | Institutional Pharmacy |
| Phone | (701) 776-5261 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Many studies published by major spinal surgery journals do not include full disclosure of researchers' financial conflicts of interest (COIs), reports a study in Spine.
Researchers have shown that the coiled-coil mimetic CCmut3 can inhibit cell growth and promote apoptosis in cell lines expressing BCR–ABL1, including those resistant to tyrosine kinase inhibitors.
Marking World Water Day Tuesday, Secretary of State Hillary Rodham Clinton, on behalf of the U.S. government, joined World Bank President Robert Zoellick in signing a Memorandum of Understanding to enhance collaborative efforts between the groups to improve water and sanitation conditions for the world's poor, the Epoch Times reports.
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
UT Southwestern Medical Center researchers report that disrupting the light-dark cycle of mice increased their susceptibility to inflammatory disease, indicating that the production of a key immune cell is controlled by the body's circadian clock.
› Verified 2 days ago
| NPI Number | 1871622308 |
| Organization Name | GOOD SAMARITAN HOSPITAL ASSOCIATION |
| Doing Business As | HEART OF AMERICA MEDICAL CENTER |
| Type | Institutional Pharmacy |
| Address | 800 S Main Ave, Rugby, ND 58368 |
| Phone Number | 701-776-5261 |
News Archive
Many studies published by major spinal surgery journals do not include full disclosure of researchers' financial conflicts of interest (COIs), reports a study in Spine.
Researchers have shown that the coiled-coil mimetic CCmut3 can inhibit cell growth and promote apoptosis in cell lines expressing BCR–ABL1, including those resistant to tyrosine kinase inhibitors.
Marking World Water Day Tuesday, Secretary of State Hillary Rodham Clinton, on behalf of the U.S. government, joined World Bank President Robert Zoellick in signing a Memorandum of Understanding to enhance collaborative efforts between the groups to improve water and sanitation conditions for the world's poor, the Epoch Times reports.
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
UT Southwestern Medical Center researchers report that disrupting the light-dark cycle of mice increased their susceptibility to inflammatory disease, indicating that the production of a key immune cell is controlled by the body's circadian clock.
› Verified 2 days ago
| NPI Number | 1922198803 |
| Organization Name | GOOD SAMARITAN HOSPITAL ASSOCIATION |
| Doing Business As | HEART OF AMERICA MEDICAL CENTER |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 800 S Main Ave, Rugby, ND 58368 |
| Phone Number | 701-776-5261 |
News Archive
Many studies published by major spinal surgery journals do not include full disclosure of researchers' financial conflicts of interest (COIs), reports a study in Spine.
Researchers have shown that the coiled-coil mimetic CCmut3 can inhibit cell growth and promote apoptosis in cell lines expressing BCR–ABL1, including those resistant to tyrosine kinase inhibitors.
Marking World Water Day Tuesday, Secretary of State Hillary Rodham Clinton, on behalf of the U.S. government, joined World Bank President Robert Zoellick in signing a Memorandum of Understanding to enhance collaborative efforts between the groups to improve water and sanitation conditions for the world's poor, the Epoch Times reports.
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
UT Southwestern Medical Center researchers report that disrupting the light-dark cycle of mice increased their susceptibility to inflammatory disease, indicating that the production of a key immune cell is controlled by the body's circadian clock.
› Verified 2 days ago
News Archive
Many studies published by major spinal surgery journals do not include full disclosure of researchers' financial conflicts of interest (COIs), reports a study in Spine.
Researchers have shown that the coiled-coil mimetic CCmut3 can inhibit cell growth and promote apoptosis in cell lines expressing BCR–ABL1, including those resistant to tyrosine kinase inhibitors.
Marking World Water Day Tuesday, Secretary of State Hillary Rodham Clinton, on behalf of the U.S. government, joined World Bank President Robert Zoellick in signing a Memorandum of Understanding to enhance collaborative efforts between the groups to improve water and sanitation conditions for the world's poor, the Epoch Times reports.
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
UT Southwestern Medical Center researchers report that disrupting the light-dark cycle of mice increased their susceptibility to inflammatory disease, indicating that the production of a key immune cell is controlled by the body's circadian clock.
› Verified 2 days ago
White Drug 050 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 107 2nd St Se, Rugby, North Dakota 58368 Phone: (701) 776-5741 | |
Good Samaritan Hospital Association Type: Institutional Pharmacy Location: 800 S Main Ave, Rugby, North Dakota 58368 Phone: (701) 776-5261 |